Is There a Link Between Dercum's Disease and HEDS

Unsplash Photo

Dercum's Disease and Hypermobile Ehlers-Danlos Syndrome (hEDS) are two conditions that often puzzle both patients and healthcare providers. While they have distinct features, some symptoms overlap, leading to questions about whether a connection exists between them. Understanding this potential link can help improve diagnosis, management, and support for those affected.

Dercum's Disease, also known as adiposis dolorosa, is a rare disorder characterized by painful fatty deposits called lipomas. These lipomas usually appear on the trunk, arms, and legs. The pain associated with these fatty lumps can be severe and chronic, often resistant to typical pain treatments.

Key features of Dercum's Disease include:

• Multiple painful lipomas beneath the skin

• Chronic, widespread pain

• Fatigue and weakness

• Possible cognitive difficulties such as memory problems

  
  

The cause of Dercum's Disease remains unclear, but it is thought to involve abnormal fat metabolism and nerve dysfunction. It primarily affects middle-aged women, although men can also develop the condition.

Both Dercum's Disease and hEDS share symptoms such as chronic pain and fatigue, which can complicate diagnosis. Patients with hEDS often report widespread pain, sometimes linked to soft tissue injuries or joint instability. Similarly, Dercum's Disease causes pain through inflamed fatty deposits.

This overlap can lead to misdiagnosis or delayed diagnosis. For example, a patient with hEDS might be mistaken for having fibromyalgia or another pain syndrome, while someone with Dercum's Disease might be treated only for lipomas without addressing systemic symptoms.

Researchers and clinicians have begun to explore whether a biological link exists between Dercum's Disease and hEDS. Some theories include:

• Connective Tissue Involvement: Since hEDS affects connective tissue, and fat tissue contains connective elements, abnormalities in connective tissue could contribute to the development of painful lipomas seen in Dercum's Disease.

• Nerve Dysfunction: Both conditions involve chronic pain that may stem from nerve irritation or damage. This suggests a possible shared pathway in how pain signals are processed.

• Inflammation and Immune Response: Some studies suggest low-grade inflammation plays a role in Dercum's Disease. hEDS patients sometimes experience immune system irregularities, which might overlap with inflammatory processes.

  
  

Despite these hypotheses, no definitive scientific evidence currently confirms a direct link. More research is needed to understand whether these conditions share underlying causes or if their coexistence in some patients is coincidental.

Recognizing the potential overlap between Dercum's Disease and hEDS can improve patient care in several ways:

• Comprehensive Evaluation: Patients presenting with chronic pain, joint hypermobility, and fatty deposits should be evaluated for both conditions. This helps avoid missed or delayed diagnoses.

• Multidisciplinary Approach: Managing these complex disorders often requires a team including rheumatologists, pain specialists, physical therapists, and sometimes surgeons.

• Tailored Pain Management: Since pain mechanisms may differ, treatments should be personalized. For example, lipomas in Dercum's Disease might respond to surgical removal or liposuction, while hEDS-related pain may improve with physical therapy and joint stabilization.

• Patient Education: Understanding the nature of these conditions empowers patients to manage symptoms better and seek appropriate support.

  
  

If you or someone you know has symptoms such as:

• Persistent, painful fatty lumps under the skin

• Joint hypermobility with frequent injuries

• Chronic widespread pain and fatigue

  
  

It is important to consult a healthcare provider familiar with rare connective tissue and pain disorders. Early diagnosis can lead to better symptom control and prevent complications.

While the exact relationship between Dercum's Disease and hEDS remains unclear, awareness of their overlapping features is growing. Ongoing research may uncover shared mechanisms that could lead to improved treatments. For now, a careful, individualized approach to diagnosis and management offers the best support for those affected.